Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Redmont Pharmaceuticals was a specialty pharmaceutical company based in Birmingham, Alabama, that focused on the acquisition and development of branded products for the hospital and specialty physician markets. The company was established by a team of experienced pharmaceutical executives, including former leaders from Sciele Pharma, with the goal of identifying niche therapeutic opportunities. Redmont's business model centered on leveraging its management's expertise to build a portfolio of high-value healthcare products. In April 2011, the company was acquired by Cumberland Pharmaceuticals, a Nashville-based specialty pharmaceutical firm. This acquisition allowed Cumberland to expand its commercial reach and business development capabilities. Following the acquisition, Redmont's operations and strategic initiatives were integrated into Cumberland's broader corporate structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Redmont Pharmaceuticals.